Evolution of the management and outcomes of patients admitted for acute myocardial infarction in France from 1995 to 2000: Data from the USIK 1995 and USIC 2000 nationwide registries;Évolution de la prise en charge et du pronostic de l'infarctus du myocarde en France entre 1995 et 2000: Résultats des études USIK 1995 et USIC 2000

Annales de Cardiologie et d'Angeiologie

Volumn 53, Issue 1, 2004, Pages 12-17

  Cambou, J P ^a   Danchin, N ^a   Boutalbi, Y ^a   Hanania, G ^a   Humbert, R ^a   Clerson, P ^a   Vaur, L ^a   Gueret P ^a   Blanchard, D ^a   Genes N ^a   Lablanche, J M ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Acute myocardial infarction; Outcome; Reperfusion therapy; Secondary prevention

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DATA ANALYSIS; DIABETES MELLITUS; EARLY DIAGNOSIS; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; MALE; MEDICAL ASSESSMENT; MULTIVARIATE ANALYSIS; PREDICTION; PRESCRIPTION; REGISTER; RISK FACTOR; SECONDARY PREVENTION; SURVIVAL RATE; TRANSLUMINAL CORONARY ANGIOPLASTY; ANGIOPLASTY; FRANCE; HEART INFARCTION; HEART STROKE VOLUME; HOSPITAL; MIDDLE AGED; MORTALITY; PROGNOSIS; STATISTICS; TREATMENT OUTCOME;

AGED; ANGIOPLASTY; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; COHORT STUDIES; FEMALE; FRANCE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROGNOSIS; RISK FACTORS; STROKE VOLUME; TREATMENT OUTCOME;

EID: 4344689615     PISSN: 00033928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ancard.2003.10.005     Document Type: Article

References (15)

1. Danchin N., Vaur L., Genès N., et al. Management of acute myocardial infarction in intensive care units in 1995: a nationwide French survey of practice and early hospital results. J. Am. Coll. Cardiol. 30:1997;1598-1605.
2. Cambou J.P., Genès N., Vaur L., et al. Épidé miologie de l'infarctus du myocarde en France. Survie à un an des patients de l'étude USIK. Arch. Mal. Coeur. 91:1998;1103-1110.
3. Danchin N., Vaur L., Genès N., et al. Treatment of acute myocardial infarction by primary coronary angioplasty or intravenous thrombolysis in the "real world": one-year results from a nation-wide French survey. Circulation. 99:1999;2639-2644.
4. Demicheli T., Cambou J.P., Vaur L., et al. Efficacité du traitement de reperfusion au stade aigu de l'infarctus dans la population âgée: données du registre USIK 1995. Ann. Cardiol. Angeiol. 51:2002;20-24.
5. Danchin N., Hanania G., Grenier O., et al. Prévenir 1, Prévenir 2 et USIC 2000. Évolution du traitement de sortie après hospitalisation pour syndrome coronaire aigu en France entre 1995 et 2000: données des études USIK 1995, Prévenir 1 et 2 et USIC 2000. Ann. Cardiol. Angéiol. 52:2003;1-6.
6. Fréquence et conditions d'hospitalisation des infarctus récents du myocarde en France. L'enquête nationale ENIM 84. Arch. Mal. Coeur. 80:1987;1853-1863.
7. Bonnefoy E., Lapostolle F., Leizorovicz A., et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet. 360:2002;825-829.
8. Andersen H.R., Nielsen T.T., Rasmussen K., et al. For the DANAMI-2 investigators. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N. Engl. J. Med. 349:2003;733-742.
9. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet. 345:1995;669-685.
10. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on six-week mortality and ventricular function after acute myocardial infarction. Lancet. 343:1994;1115-1122.
11. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N. Engl. J. Med. 342:2000;145-153.
12. Efficacy of perindopril on reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled multicentre trial (the EUROPA study). Lancet. 362:2003;782-788.
13. Schwartz G.G., Olsson A.G., Ezekowitz M.D., et al. Effects of atorvastatine on early recurrent ischemic events in acute coronary syndromes. The MIRACL study: a randomized controlled trial. JAMA. 285:2001;1711-1718.
14. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 342:1993;821-828.
15. Kober L., Torp-Pedersen C., Carlsen J.E., et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 333:1995;1670-1676.